Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-01-15NGR018: Randomized Phase II Study of NGR-hTNF Plus an Anthracycline Versus an Anthracycline Alone in Platinum-resistant Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2019-01-11Influence of a Specially Formulated Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program on Physical Performance in Cancer Outpatients
-
CLINICAL_TRIALS study record update · 2019-01-11Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2019-01-11Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells
-
CLINICAL_TRIALS study record update · 2019-01-04Clinical Protocol to Evaluate Glycans Analysis As a Diagnostic Test for Ovarian Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-01-04A Phase 1a/1b Dose Escalation and Expansion Study of SC-003 as a Single-Agent and in Combination With ABBV-181 in Subjects With Platinum-Resistant/ Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2019-01-03A Phase I/IIa, Open Label Clinical Trial Evaluating the Safety and Efficacy of Autologous T Cells Expressing Enhanced TCRs Specific for NY-ESO-1 in Patients With Recurrent or Treatment Refractory Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2018-12-27A Phase 2 Study of Kevetrin (Thioureidobutyronitrile) in Subjects With Platinum-Resistant/Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2018-12-19Lymphocyte T Regulatory , Th17 and NKT in Epithelial Ovarian Tumor- Prognostic Assessment and Relationship With Clinical Marker
-
CLINICAL_TRIALS study record update · 2018-12-04A Phase Ib, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Humanized Anti-VEGF Monoclonal Antibody(Sevacizumab) Injection Plus Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer.
-
CLINICAL_TRIALS study record update · 2018-11-20Circulating Tumor DNA Exposure in Peripheral Blood Using a Novel Process: A Feasibility Study
-
CLINICAL_TRIALS study record update · 2018-11-19A Multi-center Study of hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Post Definitive Surgery and Standard Therapy
-
CLINICAL_TRIALS study record update · 2018-11-14Non-coding RNA in the Exosome of the Epithelia Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2018-11-13Phase I of Phase I/II Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2018-11-07Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
-
CLINICAL_TRIALS study record update · 2018-11-05Sentinel Node Detection in Clinical Early Stage Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2018-10-16Phase II Evaluation of BIBF 1120 in the Treatment of Bevacizumab-Resistant, Persistent, or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2018-10-10A Phase II Study of MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
-
CLINICAL_TRIALS study record update · 2018-10-09A Phase I Scientific Exploratory Study of Epothilone B Analog in Patients With Solid Tumors and Gynecological Malignancies
-
CLINICAL_TRIALS study record update · 2018-10-09A Pilot Study for Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2018-10-05Venous Thromboembolic Complications in Patients With Ovarian Cancer Compared to Patients With Benign Ovarian Tumours
-
CLINICAL_TRIALS study record update · 2018-09-28Phase II Study Of Epothilone B Analogue BMS-247550 In Relapse And/Or Refractory Stage III Or IV Ovarian Epithelial Cancer, Following Front-Line Treatment With Platinum Plus Taxane-Based Chemotherapy
-
CLINICAL_TRIALS study record update · 2018-09-27NGR018: Randomized Phase II Study of NGR-hTNF Plus an Anthracycline Versus an Anthracycline Alone in Platinum-resistant Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2018-09-18A Phase 2, Multiple-Cohort, Open-Label, International Study of Talazoparib Monotherapy and Talazoparib Plus Temozolomide in Women With Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2018-09-18Phase II Trial of ILX295501 Administered Orally Once Weekly x 3 Repeated Every 6 Weeks in Patients With Stage III/IV Ovarian Cancer